This study is testing if a newer diabetes medication called tirzepatide can improve heart function and overall health in people who have both chronic heart failure and type 2 diabetes. 120 adults in Kazakhstan will receive the drug and be closely monitored for 40 weeks. Researche…
Phase: NA • Sponsor: Nazarbayev University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC